EH
Insider
Erik Harris
EVP & Chief Commercial OfficerErik Harris (EVP & Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $240K of RARE (10,539 sh × $22.80, as filed), executed Mar 2.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$240K
shares × price, as filed
Last traded
Mar 2
Filed Mar 3
Median ADV $57.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $876K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
RARERecent filings
RARESALE
Ultragenyx Pharmaceutical Inc.
View filing →
$240K10,539 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $636K
15,103 sh × $42.10
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET